Choriocarcinoma: Navigating risk, resistance, and remarkable curability.

Dannehl D; Taran FA

doi:10.1016/j.crwh.2025.e00772

← 뒤로

Choriocarcinoma: Navigating risk, resistance, and remarkable curability.

Case reports in women's health 2026 Vol.49() p. e00772

Dannehl D, Taran FA

PMC 전문 ↗ 원문 ↗ DOI ↗ BibTeX ↓ RIS ↓

이 논문을 인용하기

BibTeX ↓ RIS ↓

APA Dannehl D, Taran FA (2026). Choriocarcinoma: Navigating risk, resistance, and remarkable curability.. Case reports in women's health, 49, e00772. https://doi.org/10.1016/j.crwh.2025.e00772

MLA Dannehl D, et al.. "Choriocarcinoma: Navigating risk, resistance, and remarkable curability.." Case reports in women's health, vol. 49, 2026, pp. e00772.

PMID 41836078

DOI 10.1016/j.crwh.2025.e00772

같은 제1저자의 인용 많은 논문 (1)

High Adherence to Adjuvant Endocrine Therapy Improves Outcome in Early Breast Cancer - Results from a Large Real-World Claims Data Analysis in Germany.
Geburtshilfe und Frauenheilkunde 2026